CD40L induced CD86 and CD83 expression on DC but in this small study of only 26 patients, CD40L did not improve anti-tumor specific T cell proliferation, IFNγ ELISPOT response, DTH response or relapse free survival (66). This evidence concerns the gene CD40LG and neoplasm.